About us

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

United Kingdom

Kings College London

Send an Email

aida santaolalla

Address:

Research Oncology, Guy's Hospital London SE1 9RT, United Kingdom

Research Interests:

Exposure assessment Biomarkers early detection new statistical methods

Biography:

Publications:

  1. King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB).
  2. Use of a handheld terahertz pulsed imaging device to differentiate benign and malignant breast tissue.
  3. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure.
  4. Mutation of duffy antigen receptor for chemokines (DARC) as an indicator of prostate cancer severity in Afro-Caribbean men.
  5. Real World Evidence: A Quantitative and Qualitative Glance at Participant Feedback from a Free-Response Survey Investigating Experiences of a Structured Exercise Intervention for Men with Prostate Cancer.
  6. Metformin and longevity (METAL): A window of opportunity study investigating the biological effects of metformin in localised prostate cancer.
  7. The use of Latent Class Analysis to predict cancer risk based on a panel of serum biomarkers in the Swedish AMORIS study.
  8. The use of a handheld Terahertz pulsed imaging device to differentiate benign and malignant breast tissue with a view to reducing re-operation rates in breast-conserving surgery.
  9. Metabolic serum biomarkers for the prediction of cancer: A follow-up of the studies conducted in the Swedish AMORIS study.
  10. Role of serum lipids and glucose as biomarkers of prostate cancer severity..
  11. Radical prostatectomy follow up in secondary care - how long is too long?